학술논문

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
Document Type
Article
Source
In: The Lancet. (The Lancet, 11 December 2021, 398(10317):2173-2184)
Subject
Language
English
ISSN
1474547X
01406736